Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/22/2005WO2005095959A3 Methods for treating dermatological conditions in a patient
12/22/2005WO2005094533A3 Trail-r as a negative regulator of innate immune cell responses
12/22/2005WO2005089779A3 Rapidly disintegrating taste-masked tablet
12/22/2005WO2005089256A3 Antiangiogenic agents
12/22/2005WO2005086735A3 Novel bicyclic compounds as modulators of androgen receptor function and method
12/22/2005WO2005082054A3 Combinations for the treatment of fungal infections
12/22/2005WO2005082023A3 Heterocyclic self-immolative linkers and conjugates
12/22/2005WO2005080397A3 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
12/22/2005WO2005077091A3 Nicotinamide riboside kinase compositions and methods for using the same
12/22/2005WO2005076854A3 Pyrimidinone compounds useful as kinase inhibitors
12/22/2005WO2005072345A3 Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors
12/22/2005WO2005072274A3 Autoinducer-2 compounds as immunomodulatory agents
12/22/2005WO2005072082A3 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005WO2005063697A3 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
12/22/2005WO2005062985A8 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
12/22/2005WO2005060945A3 Intranasal compositions comprising zolpidem
12/22/2005WO2005060663A3 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
12/22/2005WO2005059102A3 METHOD FOR OBTAINING AN ENRICHED POPULATION OF siRNA-EXPRESSING CELLS
12/22/2005WO2005058231A3 Rifamycin analogs and uses thereof
12/22/2005WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives
12/22/2005WO2005051321A3 Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase
12/22/2005WO2005046634A8 Gastric juice-resistant form of administration
12/22/2005WO2005034737A3 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases
12/22/2005WO2005032466A3 Calcium phosphate-based materials containig zinc, magnesium, fluoride and carbonate
12/22/2005WO2005030177A3 Pharmaceutical formulation with improved stability
12/22/2005WO2005030125A3 Method of treating smallpox and monkeypox
12/22/2005WO2005027842A3 Combinations of drugs for the treatment of neoplasms
12/22/2005WO2005025410A3 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane
12/22/2005WO2005023233A3 Antimicrobial compositions and methods
12/22/2005WO2005000216A8 Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
12/22/2005WO2004110389A3 Sigma ligands for neuronal regeneration and functional recovery
12/22/2005WO2004106296A3 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/22/2005WO2004098512A3 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
12/22/2005WO2004093823A3 Polyethelene glycol link glp-1 compounds
12/22/2005WO2004082621A3 Novel ppar agonists, pharmaceutical compositions and uses thereof
12/22/2005WO2004078117A3 Method for increasing hair growth
12/22/2005WO2004076637A3 Cell-polymer fiber compositions and use thereof
12/22/2005WO2004062580A3 Odorless formulation for treating mucosal discontinuities
12/22/2005WO2004058159A3 Branched immunomodulatory compounds and methods of using the same
12/22/2005WO2004026107A3 Kits and methods for assessing skin health
12/22/2005WO2003049687A3 Medicinal compositions & therapeutic methods
12/22/2005US20050283846 Method for evaluating therapeutic agent for dermatitis and/or alopecia, therapeutic agent for dermatitis and/or alopecia, and transgenic mouse
12/22/2005US20050283842 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis
12/22/2005US20050283841 Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050283007 adamanolol; 1'-(adamantane-1-carbonyl)-[4,4']bipiperidinyl-1-carboxylic acid [2-hydroxy-3-3-(1H-indol-4-yloxy)-propyl]-isopropyl-amide;human epidermal growth factor receptor antagonist; alpha-helix mimetics of Sur-2 (supressor of Ras); anticarcinogenic agent; breast cancer
12/22/2005US20050283005 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282913 Abnormal cannabidiols as agents for lowering intraocular pressure
12/22/2005US20050282912 Abnormal cannabidiols as neuroprotective agents for the eye
12/22/2005US20050282911 Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality
12/22/2005US20050282910 Methods of application of chemical compounds having therapeutic activities in treating cancers
12/22/2005US20050282909 Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282906 Neural tourniquet
12/22/2005US20050282904 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
12/22/2005US20050282903 Use of Treprostinil to treat neuropathic diabetic foot ulcers
12/22/2005US20050282902 Abnormal cannabidiols as agents for lowering intraocular pressure
12/22/2005US20050282901 Compounds and methods for delivery of prostacyclin analogs
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282898 Methods for the synthesis of milnacipran and congeners thereof
12/22/2005US20050282897 Methods and compositions for treating diabetes
12/22/2005US20050282896 Methods of cardioprotection using dichloroacetate in combination with an inotrope
12/22/2005US20050282895 Antimicrobial compositions and methods of use thereof
12/22/2005US20050282894 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
12/22/2005US20050282893 Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors
12/22/2005US20050282892 Pharmaceutical composition useful for treating chronic myeloid leukemia
12/22/2005US20050282891 Parkinson's disease, depression, attention deficit disorder; schizophrenia, manic depression, cognitive impairment disorders, restless legs syndrome, periodic limb movement disorders, Huntington's disease, Tourette's syndrome, congestive heart failure, sustained release
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282887 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
12/22/2005US20050282886 Lactam tachykinin receptor antagonists
12/22/2005US20050282885 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/22/2005US20050282884 N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use
12/22/2005US20050282883 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282879 Methods and composition for treatment of migraine and symptoms thereof
12/22/2005US20050282878 Process for the purification of fluconazole
12/22/2005US20050282877 Method of decreasing inflammation in kidney transplantion using angiotensin receptor blockers
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282874 For therapy of allergic disorders (e.g., immunodeficiency diseases and hypersensitivity); cardiovascular disorders (e.g., hypertension and arteriosclerosis); dental and oral disorders (e.g., inflammation of the oral mucosa); dermatologic disorders (e.g., dermatitis and skin infections)
12/22/2005US20050282873 Epothilone derivative for the treatment of hepatoma and other cancer diseases
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
12/22/2005US20050282870 Peripherally-acting vasodilators
12/22/2005US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
12/22/2005US20050282868 Substituted anthranilamides for controlling invertebrate pests
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282865 Neurotrophic factor production promoter
12/22/2005US20050282863 Novel-N substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282860 Fexofenadine polymorphs and process for the preparation thereof
12/22/2005US20050282859 Dual acting SNRI-NMDA antagonists for the treatment of genitourinary disorders
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282857 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes
1 ... 4424 4425 4426 4427 4428 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 4440 4441 4442 4443 4444 ... 7860